Table 2 Implant success rates, scores (CHA₂DS₂-VASc or CHADS₂ and HAS-BLED), procedural data and anesthesia type

Chen et al. (2019) [21]

CHA₂DS₂-VASc:

3.9 ± 1.5

4.1 + 1.0

100%

29.0 ± 10.1

3.5 ± 1.9

N/A

N/A

CS: n = 30/100%

N/A

Feng et al. (2019) [22]

CHADS₂:

2.5 ± 1.1

2.7 + 0.8

100%

67.2 ± 11.9

18.6 ± 14.4

N/A

N/A

N/A

63.6 ± 4.4

Reinsch et al. (2018) [19]

CHA₂DS₂-VASc:

3.3 + 1.0

3.0 + 1.0

100%

65.1 ± 27.2

7.1 ± 2.7

< 50

N/A

CS: n = 11/100%

48.5+  9.1

Park et al. (2018) [18]

CHA₂DS₂-VASc:

4.0 + 1.6

3.2 + 1.3

100% ^a

33.9 ± 17.6

12.7 ± 4.8

97.2 ± 44

N/A

CS:

n = 23/38.3%

General:

n = 37/61.7%

58.0 ± 6.9

Kleinecke et al. (2018) [17]

CHA₂DS₂-VASc:

5.0 + 2.0

3.7 + 1.3

100%

23.4 ± 9.2

11.9 ± 4.1

96.2 ± 45.7

2718.4 ± 3835.3

N/A

56.4 ± 9.2

Cruz-Gonzalez et al. (2017) [20]

CHA₂DS₂-VASc:

5.4 + 1.0

3.3 + 0.8

100%

N/A

N/A

N/A

N/A

N/A

N/A

Chen et al. (2018) [9]

CHA₂DS₂-VASc:

3.9 + 1.5

4.1 + 1.0

100%

29.0 ± 10.1

3.5 ± 1.9

N/A

N/A

N/A

N/A

Zhou et al. (2017) [16]

CHA₂DS₂-VASc:

3.9 + 1.3

N/A

100%

49.7  ±   9.1

N/A

N/A

N/A

N/A

53.9 ± 6.1

Huang et al. (2017) [15]

CHA₂DS₂-VASc:

4.0 + 1.7

N/A

99.3%

(n = 152/153)

66.0 ± 24.0

N/A

N/A

N/A

General:

n = 152/100%

N/A

Jie et al. (2016) [14]

CHADS₂:

2.4 ± 1.3

N/A

N/A

N/A

N/A

N/A

N/A

N/A

61.0 ± 8.5

Total /

Overall mean

CHA₂DS₂-VASc:

4.0 + 0.9

3.4 + 0.5

99.7%

(n = 348/349)

45.4 ± 18.7

9.6 ± 5.9

96.7 ± 0.7

CS:

n = 64/25.2%

General:

n = 189/74.4%

56.9 ± 5.3